Pilot study on interferon gamma in association with peg-interferon alpha 2a and ribavirin among patients with a chronic hepatitis C and non responders to the association of peg-interferon alpha 2b or 2a and ribavirin ANRS HC16 Gammatri
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2007
At a glance
- Drugs Interferon gamma; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Aug 2007 Status changed from terminated to completed.
- 18 Nov 2005 New trial record.